Silencing VDAC1 Expression by siRNA Inhibits Cancer Cell Proliferation and Tumor Growth In Vivo.
about
Mechanistic Nanotherapeutic Approach Based on siRNA-Mediated DJ-1 Protein Suppression for Platinum-Resistant Ovarian CancerMitochondrial VDAC1: A Key Gatekeeper as Potential Therapeutic TargetArgininosuccinate synthetase 1 suppression and arginine restriction inhibit cell migration in gastric cancer cell lines.Novel Biomarker Proteins in Chronic Lymphocytic Leukemia: Impact on Diagnosis, Prognosis and Treatment.Knockout of Vdac1 activates hypoxia-inducible factor through reactive oxygen species generation and induces tumor growth by promoting metabolic reprogramming and inflammation.Non-Overlapping Distributions and Functions of the VDAC Family in Ciliogenesis.Structural Dynamics of Human Argonaute2 and Its Interaction with siRNAs Designed to Target Mutant tdp43.Clinical implication of voltage-dependent anion channel 1 in uterine cervical cancer and its action on cervical cancer cells.Long non-coding RNA EWSAT1 promotes human nasopharyngeal carcinoma cell growth in vitro by targeting miR-326/-330-5p.Decreased expression of microRNA-320a promotes proliferation and invasion of non-small cell lung cancer cells by increasing VDAC1 expression.Proteomics-based identification of VDAC1 as a tumor promoter in cervical carcinomaThe Mitochondrial Voltage-Dependent Anion Channel 1, Ca2+ Transport, Apoptosis, and Their Regulation.Bioorthogonal Labeling of Human Prostate Cancer Tissue Slice Cultures for Glycoproteomics.The Roles of Mitochondrial Cation Channels Under Physiological Conditions and in Cancer.The Close Interconnection between Mitochondrial Dynamics and Mitophagy in Cancer.p53 and Ca(2+) signaling from the endoplasmic reticulum: partners in anti-cancer therapies.Novel insights into role of miR-320a-VDAC1 axis in astrocyte-mediated neuronal damage in neuroAIDS.MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis.Voltage-Dependent Anion Channel 1 As an Emerging Drug Target for Novel Anti-Cancer Therapeutics.The Regulation of Tumor Cell Invasion and Metastasis by Endoplasmic Reticulum-to-Mitochondrial Ca2+ Transfer.Long intergenic non-protein coding RNA 00858 functions as a competing endogenous RNA for miR-422a to facilitate the cell growth in non-small cell lung cancer.A molecular signature of lung cancer: potential biomarkers for adenocarcinoma and squamous cell carcinoma.Novel function of ceramide for regulation of mitochondrial ATP release in astrocytes.Differential proteome profiling in the hippocampus of amnesic mice.VDAC1 is a molecular target in glioblastoma, with its depletion leading to reprogrammed metabolism and reversed oncogenic properties.A flexible microneedle array as low-voltage electroporation electrodes for in vivo DNA and siRNA delivery.MiR-490-3p Functions As a Tumor Suppressor by Inhibiting Oncogene VDAC1 Expression in Colorectal Cancer.Targeting Liver Cancer and Associated Pathologies in Mice with a Mitochondrial VDAC1-Based Peptide.
P2860
Q29247912-73A99DA0-3CC6-4910-BA43-9F33FC401607Q33854939-DA227ECC-A991-4944-B84F-B6125CFBC14EQ35556985-0817CE94-49B6-46FF-8524-28BB73A3B9C5Q35990061-D45E261A-EE1F-4693-91A4-AB6728D0AA3CQ36002110-6BC8A19E-06F8-4013-AB30-84459A9BFE14Q36105568-90A0D9BA-8995-40D8-A70E-8EC83B86DD65Q36775620-E05562F9-DD2B-467D-8320-4BE5E2692A97Q36782401-94565796-9BC0-467F-AB45-8ABA224C7A28Q37530948-C417FEC3-6CEC-4F66-BAE9-78A4A12BF627Q37580258-872CECB1-9F3A-4B7A-86B1-008CFE190C83Q37588452-A23386C5-737C-4D52-B200-A59F6F1FE863Q37742829-B2517E74-B82A-4739-8498-965723267064Q38709426-A2E4FC41-F14F-4D37-B810-C0CCFDE9F2D9Q39044112-1CFA819C-8728-43F5-945E-F04C8903EDE7Q39312378-E404AF40-4C18-413E-956D-92637C1203B8Q39542732-247287F6-95DB-43E4-9897-5F7F1BA84E2AQ40497318-3CE7C34F-2A99-4CB4-949C-C82C7127F30AQ40937830-12130292-FABF-4503-BA0B-7E4422B32324Q41173095-955F37E6-4C88-416D-9229-EE7D6C441AE4Q41366716-6E726EA6-613C-4E32-9F32-192FB0498548Q42314770-216C756A-5C2D-4F50-9B39-B28E84A1C1FCQ47093693-B6F25CEF-14E6-4F02-85EB-CBC3B56925CCQ47872027-596124D5-2994-4472-A84D-49FA82ECA59DQ48062739-7F3784A6-00B7-42B8-B862-558E07983CCDQ48246912-CB527AC2-C67B-4282-AF00-D52D5E80F4B4Q51509343-B6030CCB-A2F5-409A-8BEC-A8176678F4ACQ52576042-9C2A9A6D-6862-40F0-B973-15C5EDE63FBCQ55255442-EDF227A8-8000-43C8-B2FB-E5C8B5458C6E
P2860
Silencing VDAC1 Expression by siRNA Inhibits Cancer Cell Proliferation and Tumor Growth In Vivo.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Silencing VDAC1 Expression by ...... tion and Tumor Growth In Vivo.
@ast
Silencing VDAC1 Expression by ...... tion and Tumor Growth In Vivo.
@en
Silencing VDAC1 Expression by ...... tion and Tumor Growth In Vivo.
@nl
type
label
Silencing VDAC1 Expression by ...... tion and Tumor Growth In Vivo.
@ast
Silencing VDAC1 Expression by ...... tion and Tumor Growth In Vivo.
@en
Silencing VDAC1 Expression by ...... tion and Tumor Growth In Vivo.
@nl
prefLabel
Silencing VDAC1 Expression by ...... tion and Tumor Growth In Vivo.
@ast
Silencing VDAC1 Expression by ...... tion and Tumor Growth In Vivo.
@en
Silencing VDAC1 Expression by ...... tion and Tumor Growth In Vivo.
@nl
P2093
P2860
P356
P1476
Silencing VDAC1 Expression by ...... tion and Tumor Growth In Vivo.
@en
P2093
Alexander Konson
Lilia Vasilkovsky
Varda Shoshan-Barmatz
Yael Refaely
P2860
P356
10.1038/MTNA.2014.9
P50
P577
2014-04-29T00:00:00Z